Cabozantinib-d6 is a deuterium-labeled derivative of Cabozantinib, a potent inhibitor targeting multiple receptor tyrosine kinases (RTKs) including VEGFR2, c-Met, Kit, Axl, and Flt3. This compound is designed for research applications, serving as a valuable tracer or internal standard for precise quantitative analysis methods such as NMR, GC-MS, and LC-MS.
- Deuterium-labeled compound
- Potent inhibitor of multiple receptor tyrosine kinases
- Inhibits VEGFR2, c-Met, Kit, Axl, and Flt3
- Useful as a tracer in research
- Functions as an internal standard for quantitative analysis
- Compatible with NMR, GC-MS, and LC-MS techniques
- Intended for research use only